What Changed
Price Move History
- Daily moves over 5%
- 2 7 sessions, March 5, 2026 to November 4, 2026
- Largest daily move
- +2700% close of April 7, 2026
Company Description
MediXall Group (OTC: MDXL) is classified in the health information services industry within the Healthcare sector and carries a market capitalization of $678.2K.
For FY2023, MediXall Group reported revenue of $309K with net income of -$4.6M and diluted earnings per share of -$0.04.
This page collects what Stock Titan holds for MDXL, including price data, latest news, SEC filings, and financial highlights.
Stock Performance
MediXall Group (MDXL) closed at $0.0033 on November 4, 2026.
See what a $1,000 investment in MDXL was worth at its last close
MDXL Metrics & Rankings
Price returns through November 4, 2026. Ranking links may use different dates.
Latest News
MediXall Group has 10 recent news articles. Key topics include partnership, AI, conferences. View all MDXL news →
SEC Filings
MediXall Group has filed 4 recent SEC filings, including 3 Form NT 10-Q, 1 Form NT 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MDXL SEC filings →
Financial Highlights
MediXall Group generated $309K in revenue in FY2023, retaining a 23.6% gross margin, and net income was -$4.6M. Diluted earnings per share stood at -$0.04. The company generated -$1.2M in operating cash flow. The current ratio was 0.00, measuring current assets divided by current liabilities.
Upcoming Events
MDXL Company Profile & Sector Positioning
MediXall Group (MDXL) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MDXL often look at related companies in the same sector, including Cardiocom Sltns Inc (EKGGF), Dogecoin Cash Inc (DOGP), Nano Mobile Healthcare (VNTH), PPJ Healthcare Enterprise (PPJE), and EcoPlus Inc (ECPL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MDXL's relative position within its industry.